Roeland Zoutendijk

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

P. Arends, Milan J. Sonneveld, Roeland Zoutendijk et al. · Gut · 2014 · 207 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

Roeland Zoutendijk, Jurriën G.P. Reijnders, Fabien Zoulim et al. · Gut · 2012 · 186 citations

Medicine, Infectious Diseases, Pharmacotherapy +17

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown et al. · Hepatology · 2011 · 171 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

Roeland Zoutendijk, Bettina E. Hansen, Anneke J. van Vuuren et al. · The Journal of Infectious Diseases · 2011 · 143 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV

Roeland Zoutendijk, Hans L. Zaaijer, T.E.M.S. de Vries-Sluijs et al. · The Journal of Infectious Diseases · 2012 · 80 citations · Full text

Pharmacy, Immunology, Infectious Diseases +16